Å6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: A phase I trial-Reference-Cited by-同舟云学术

Å6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: A phase I trial

Published:2005-10 Issue:1 Volume:99 Page:50-57
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Berkenblit Anna,Matulonis Ursula A.,Kroener Joan F.,Dezube Bruce J.,Lam Gil N.,Cuasay Luceli C.,Brünner Nils,Jones Terence R.,Silverman Michael H.,Gold Michael A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference32 articles.

1. Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients;Look;J. Natl. Cancer Inst.,2002

2. Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients;Look;Thromb. Haemost.,2003

3. Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer;Harbeck;Thromb. Haemost.,2004

4. Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424);Harbeck;Cancer Res.,2002

5. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases;Riisbro;Gynecol. Oncol.,2001

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational peptide design for targeting cancer cell invasion;Proteins: Structure, Function, and Bioinformatics;2023-08-30

2. uPAR, beyond regulating physiological functions, has orchestrated roles in cancer (Review);International Journal of Oncology;2022-10-18

3. Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer;International Journal of Gynecologic Cancer;2022-06-24

4. The membrane receptor CD44: novel insights into metabolism;Trends in Endocrinology & Metabolism;2022-05

5. Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View;Frontiers in Cell and Developmental Biology;2022-04-08